SNTI
Senti Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$28.81M
P/E Ratio
—
EPS
$-2.73
Beta
2.12
52W High
$3.88
52W Low
$0.77
50-Day MA
$0.94
200-Day MA
$1.39
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Senti Biosciences Inc
Senti Biosciences Inc (SNTI) is an innovative biotechnology company at the forefront of synthetic biology, dedicated to pioneering next-generation cell and gene therapies. Utilizing its proprietary GeneCircuit platform, the company is developing programmable therapies aimed at treating a spectrum of diseases, including cancer and genetic disorders, thereby enhancing the precision of personalized medicine. With a robust development pipeline and strong strategic partnerships, Senti is strategically positioned to drive advancements in engineered cell therapies, offering transformative solutions to address critical unmet medical needs in the biopharmaceutical sector.
Fundamentals
| Revenue (TTM) | 22,000 |
| Gross Profit (TTM) | $-37.56M |
| EBITDA | $-54.67M |
| Operating Margin | -37095.00% |
| Return on Equity | -218.10% |
| Return on Assets | -48.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.18 |
| Price-to-Book | 5.49 |
| Price-to-Sales (TTM) | 1309.35 |
| EV/Revenue | 1960.72 |
| EV/EBITDA | -0.28 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $31.14M |
| Float | $14.58M |
| % Insiders | 47.60% |
| % Institutions | 18.45% |
Historical Volatility
HV 10-Day
127.95%
HV 20-Day
95.76%
HV 30-Day
90.67%
HV 60-Day
82.18%
HV Rank
—
Volatility is currently expanding
Data last updated: 5/1/2026